Yahoo Web Search

Search results

1. • 

     Thick Toenails

     Health via Yahoo News· 15 hours ago

     This condition can develop from a nail injury, an allergic reaction, psoriasis, or other conditions. Repeated trauma to the nail from over-filing or an...

2. • 

     Finding the Best Psoriasis Treatment: How I Got Psoriasis Relief

     Verywell Health via Yahoo News· 5 days ago

     Takeaway Humira was one of the first biologic medications approved for psoriatic arthritis in 2005...

3. • Ultravate side effects: What they are and how to manage them

     Healthline· 6 days ago

     Ultravate (halobetasol propionate) is a prescription drug that’s used to treat plaque psoriasis. Ultravate can cause side effects that range from mild to serious. Specifically ...

4. • 

     Why Do I Have a Rash Between My Breasts?

     Verywell Health via Yahoo News· 2 days ago

     A rash between the breasts can develop for a variety of reasons, including heat, infection, or other more serious conditions like cancer. Here’s what to...

5. • 

     State board targets six prescription drugs to review for affordability for Marylanders

     Maryland Matters via Yahoo News· 5 days ago

     The board will seek public comments, additional information and data over the next 60 days to...

6. • Teva and Alvotech Announce SIMLANDI® (adalimumab-ryvk) Injection Now Available in the U.S. -...

     Benzinga· 5 days ago

     "We are proud to make SIMLANDI available in the U.S. to patients and providers," said Thomas Rainey, Senior Vice President, U.S. ...

7. • TREMFYA® (guselkumab) QUASAR Maintenance Study in UC met its primary endpoint and all major...

     FOX 23 News Albany· 6 days ago

     ...20, 2024 /PRNewswire/ -- Johnson & Johnson today announced the first data from the Phase 3 QUASAR Maintenance Study (Abstract #759) that showed 50.0 percent (p<0.001) of patients with moderately to severely active ulcerative colitisa (UC) receiving subcutaneous (SC) TREMFYA® (guselkumab) 200 mg...

8. • UCB Announces Publication in The Lancet of Phase 3 BIMZELX® (bimekizumab-bkzx) Trials in...

     KTLA-TV Los Angeles· 3 days ago

     In these studies, bimekizumab consistently demonstrated sustained improvements in clinical- as well as patient...

9. • 

     Stress can be "the triggering factor" for skin problems. Dermatologists share their advice.

     CBS News· 5 days ago

     There are many ways mental health can impact our physical health — but did you know stress can even...

10. • 

      Do LED Skin-Care Devices Even Work?

      New York Magazine· 5 days ago

      Light therapy via at-home LED (light-emitting diodes) devices is trending in skin care right now, but it’s not just a fad. According to Dr. Jared Jagdeo,...